189 results
Page 2 of 10
6-K
EX-99.5
7g0n7aocwn
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
b7p57m6
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.2
bvw61iwmq4kg4hoz9i9
25 Oct 22
Current report (foreign)
12:27pm
20-F/A
m4isylpzi7z7urr
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
dju6ul4hqwslx64ref
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.2
jrv8r6avdl dssn1ceb
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
lcqhs9ifhhs n6
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
qnic g0e7bxz
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
hpetbt23iwrzps4m5h
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.3
h2o 7l467
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
oweegbho
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
3rfo5 eczzbbzun
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.4
eia8smp9hwv
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
2r7dvd1m5u765376540
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
1cwnqxw8tv
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
thc3 0boie
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
3gauqpge4nzkj5o
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
3mb0j62ojx 72
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.4
c9crkuuo
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm